Dr. Werner Mederski

Food Ingredients

A compendium of flavorings and more

• Broschiertes Buch

Produktbeschreibung

Ingredients for Food is a comprehensive reference book or compendium for [hobby] cooks,who are interested in flavors and related information on chemical structures.A total of 28 chapters present and discuss aroma compounds and their molecular structures.Emphasis is placed on the fruit flavors [Chapter 3], vegetables/salad [Chapter 11], spices [Chapter 13], herbs [Chapter 16], nuts [Chapter 19], mushrooms [Chapter 20], and wild herbs [Chapter 27].Furthermore, there are chapters that discuss certain properties of flavors: Heating [Chapter 1], critical flavors, [Chapter 2], olfactory flavors [Chapter 4], sulfurous flavors [Chapter 5], toxicity [Chapter 6], umami/flavor enhancers [Chapter 12], and healing effects [Chapter 14].In addition, always linked to the Chemical Structures, bitter compounds [Chapter 7], essential oils [Chapter 10], colorants [Chapter 9], fats/oils [Chapter 10], binders/hydrocolloids/emulsifiers [Chapter 15] as well as binders [Chapter 25], proteins/proteins [Chapter 21], sharpness [Chapter 23], vitamins [Chapter 26], and sugars/polysaccharides [Chapter 28] are discussed.Also presented are mixtures of spices and herbs [Chapters 17 and 18].For those interested in structure, a chapter [24] on trivial names is provided.

Produktdetails

• Verlag: epubli
• Seitenzahl: 208
• Englisch
• Abmessung: 297mm x 210mm x 12mm
• Gewicht: 554g
• ISBN-13: 9783754115992
• Artikelnr.: 61761289

Autorenporträt

Mederski, Dr. Werner§Born in Hanover in 1956. 1976 A-levels at the Bismarckschule in Hanover. 1986 Studied chemistry at the Technical University of Hanover, graduating with a doctorate in organic chemistry under Prof. Dr. Dr. Ekkehard Winterfeldt. 1986-2019 Worked in the field of medicinal chemistry at MERCK KGaA in various functions: Focus on synthesis of small organic molecules for preclinical and clinical development in various medical indications [from antihypertensives to oncology]. Currently in 2020 peposertib / clinical phases I and IIa as DNA-PK inhibitor.